NatureWell, Inc. Launches Improved Corporate And Product Websites

Main Category: Headache / Migraine
Also Included In: IT / Internet / E-mail
Article Date: 04 Aug 2006 - 0:00 PDT

email to a friend   printer friendly   opinions  

NatureWell, Incorporated (the "Company") (OTC Bulletin Board: NAWL), today announced the launch of a new corporate website in addition to a redesigned website for its flagship product MigraSpray.

The product website, http://www.MigraSpray.com, was designed and programmed to better meet the needs of both healthcare practitioners and individual consumers. The new site provides an exclusive section for healthcare practitioners, accessible only by a log-in verification process, in which they can place orders, take advantage of special offers, view prescribing information and have access to other more detailed information. Additionally, the Company has improved the ordering process for consumers and practitioners by providing a more sophisticated and streamlined e-commerce solution.

The new corporate website, available by visiting http://www.NatureWell.com, provides up-to-date company information directed towards the investment community. The site includes product information, market facts, SEC filings, news releases and more.

James R. Arabia, Chairman and Chief Executive Officer, commented, "We believe the redesign of our MigraSpray.com website will significantly enhance our unique distribution strategy by better facilitating sales and building a new brand identity for MigraSpray that is needed to tap into the U.S. market for migraine "treatment" remedies, currently estimated at $1.5 billion annually, and the migraine prevention market which is valued at nearly $3.5 billion annually. Our new corporate website will better facilitate communication between the Company and the investment community. We intend to continually update the sites to improve performance, navigability and functionality in the future to better serve our investors and customers."

About NatureWell, Incorporated:

NatureWell, Incorporated is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products. The Company currently markets its flagship product MigraSpray, a patented, over-the-counter, homeopathic drug intended to be a comprehensive approach for the treatment and prevention of migraine headaches.

Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the "safe harbor" provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.

NatureWell, Incorporated
http://www.MigraSpray.com

• Additional
• References
• Citations